EHA-ASH Translational Research Training in Hematology
The call is now closed, the next call opens early spring 2023.
What is Translational Research Training in Hematology?
Translational Research Training in Hematology (TRTH) provides early-career researchers with a unique, year-long training and mentoring experience. TRTH is a joint effort of the European Hematology Association (EHA) and the American Society of Hematology (ASH) and is focused on helping early-career hematological scientists build successful careers in hematological translational research. The TRTH program begins with an intensive week-long course held in the spring. Mornings are dedicated to didactic and interactive sessions which further participants' understanding of translational research methodology and career development. Afternoons are devoted to small group sessions in which participants meet with their TRTH mentors, peers, and faculty to refine their individual research proposals. Informal presentations by leaders in hematology, designed to illustrate the variety of pathways to a successful career in hematology research, take place in the evenings.
This program is made possible through the generous support of unrestricted grants from:
- Celgene (Premium sponsor)
- Janssen Pharmaceutica NV (Premium sponsor)
- F. Hoffmann-La Roche Ltd. (TRTH program supporter)
How to apply for TRTH
Find out how to submit your letter of intent and what is required.
Is TRTH for me?
You may be surprised. Click here and find out whether you could be a match.
What can I expect from TRTH?
Find out about the faculty, the learning objectives and how the program is built.
When and where do the meetings take place? Are there costs for you?
For mentors of applicants
If your associate is applying for TRTH, please read this information about what is expected from you and your institute.
Past winners of TRTH
Past recipients of this prestigious award